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In the African setting with improvement in iodine supplementation by iodization of salt and drinking 
water; Graves disease may become more prominent as the main aetiology of thyrotoxicosis as toxic 
nodular goitre used to rank side by side in the causation of thyrotoxicosis. A report of Graves disease is 
being made among three black African Nigerian families. Graves' disease is an autoimmune disorder 
which is said not to be prevalent in the African continent because of the low prevalence of other 
autoimmune diseases. However, viruses and bacteria have been generally associated with its causation in 
genetically prone individuals. There is need for genetic analysis to be carried out in these types of cases as 
it will be of interest to document familial Graves' disease and its genetic nature in the blacks as not many 
cases have been reported. This will help to design the best  treatment for each individual case.
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INTRODUCTION:
Graves' disease was first described in 1835 by an 
Irish Physician, Robert James Graves, to consist of 
goitre and exophthalmos. In 1840, the German Karl 
Adoph Von Basedow independently reported this 
association and noted same symptoms. Thus, it is 
also known as Basedow's disease on the European 
continent. Several earlier reports exist but were not 
circulated like those by Italians Giuseppe Flajani 
and Antonio Giuseppe Testa in 1802 and 1810 
respectively. Prior to these, Caleb Hillier Parry, a 
Physician in England of the late 18th century, 
described a case in 1786, which was not published 
until 1825. Sayyid Ismail Al-Jurjani in the 20th 
century described the association between goitre 
1, 2, 3
and exophthalmos
Graves' disease is more prevalent in females than 
3, 4, 5males and the female to male ratio is 7  8:1 .
The diagnostic features of Graves' disease are 
exophthalmos, which is due to immunoglobulins 
and lymphocytic infiltration. It is more common in 
smokers even after treatment in the smoker and can 
occur for the first time after radioiodine therapy. 
The second diagnostic feature of Graves' disease is
pretibial myxoedema, which is also due to 
immunoglobulin and lymphocyte infiltration. This 
result in fluid retention and swelling of the skin of 
the shin. The third diagnostic criterion is the 
presence of diffuse goitre which may be small but 
visible and may be present in other causes of 
4, 5
thyrotoxicosis .
Graves' disease is associated with the presence of 
thyrotropin receptor autoantibodies. These are 
thyroid stimulating immunoglobulins (TSI), 
thyroid growth immunoglobulins (TGI) and thyroid 
binding inhibiting immunoglobulins (TBII). 
Thyroid stimulating immunoglobulins act as long 
acting thyroid  stimulant (LATS) activating the 
cells in a longer and slower way than (TSH) 
thyrotropin, leading to an elevated production of 
1
t h y r o i d  h o r m o n e s .  T h y r o i d  g r o w t h  
immunoglobulins bind directly to the thyrotropin 
receptors and have been implicated in the growth of 
thyroid follicles. Thyroid binding inhibiting 
immunoglobulins inhibit the normal union of 
thyrotropin and its receptors. By this inhibition, 
several other antibodies that normally would inhibit 
thyrotropin function, will actually act as if 
thyrotropin itself was binding to its receptor, thus, 
inducing increase in thyroid function.
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There is a marked family preponderance which has 
led to speculation that there may be a genetic 
1
component . However, no clear genetic defect has 
been found that would point at a monogenic cause. 
The trigger for auto antibody production is not 
known. Human leukocyte antigen, HLA DR 
                      
( e s p e c i a l l y  D R 3 )  a p p e a r s  t o  p l a y  a  
7, 8, 9significant role .
Since Graves' disease, autoimmune disease, 
appears suddenly, often quite late in life, it is 
thought that a viral or bacterial infection may 
trigger antibody formation which cross  react with 
5, 6the human thyrotropin receptors . One possible 
culprit is thought to be the bacterium, Yersinia 
3enterocolitica . However, although, there is direct 
evidence for the structural similarity between the 
human thyrotropin receptor, direct causative 
evidence is limited. Yersinia seems not to be a 
major cause of this disease, although, it may 
contribute to the development of thyroid 
autoimmunity arising for other reasons in 
9
genetically susceptible individuals . It has also 
been suggested that . It has also been suggested that 
Y. enterocolitica infection is not the cause of 
autoimmune thyroid disease but rather, is only an 
associated condition with both having a shared 
3inherited susceptibility .
Genetic factors are important but not determinative 
in the development of Graves' disease. Twin 
studies show a 20% concordance with 
monozygotic twins and lower rates with dizygotic 
9twins and other HLA-identicalsiblings . Studies 
have found that several HLA alleles have been 
shown to predispose certain groups to the disease 
with regional and racial variations. These HLA 
alleles in British Caucasians include HLA Class II 
alleles DRB1- 0304, DQB1- 02 and DQA1- 0501 
while North in American Caucasians, the 
susceptibility genes are DRB1*03/DRB3*0101 
and DRB3*0202 while DRB1*07 is protective 
against Graves' disease in the North American 
1, 5, 6Caucasians . However, for African Americans, 
their susceptibility gene for Graves' disease is HLA 
8DRB3*020/DQA1*0501 . The association of HLA 
alleles with susceptibility to Graves' disease is 
typical of an autoimmune disorder.
Genetic analysis has shown that polymorphism in 
the cytotoxic T-lymphocyte antigen 4 (CLTA - 4) 
gene, is associated with Graves' disease. CTLA - 4 
is a receptor expressed on activated T cells 
proliferation by binding to the co-stimulatory B7 
molecule and prevents further activation. The 
polymorphism corresponds with lessened 
effectiveness of this inhibitory receptor. CTLA - 4 
has also been linked to organ - specific autoimmune 
7diseases .
Another gene is the vitamin D - binding protein 
gene. Polymorphism of this gene has been 
associated with susceptibility to Graves' disease but 
mechanism of association is not known. Graves' 
disease patients have been shown to have low 
9
vitamin D in circulation .
CASE REPORTS:
First Family:
The index  case of this family is M.V.M.V. was a    
38 year old female school teacher who presented 
with a 9 month history of bulging of both eye balls, 
that were painful and there was an associated 
thyroid enlargement. She also had features of 
thyrotoxicosis, such as palpitations, shaking of the 
body, hyperdefaecation, and weight loss. She never 
had a spontaneous abortion. Patient's immediate 
elder sister had similar symptoms for which she was 
receiving treatment in a specialist hospital. She 
brought the sister later for further management. 
Examination revealed a young woman with coarse 
tremors of the whole body. She had exophthalmos 
with diffuse goitre that was not tender to touch. She 
had palmar erythema, onycholysis, warm moist 
palms, tachycardia of 120/minute regular and 
hypertension - 190/120mmHg. Her serum thyroid 
hormone levels were elevated (thyroxine = 
327nmol/L, thyrotropin = 0.2m.i.u/L). Packed cell 
volume, white cell count, serum albumin and serum 
calcium and phosphorus were all within the 
laboratory's reference range for their assays. A 
diagnosis of Graves' disease was made.
This patient brought her elder sister with a three -  
month history of progressive bilateral protrusion of 
the eye balls and a goitre that was not painful. She 
had been prescribed carbimazole and propranolol 
from a peripheral hospital for one month which 
finished a month before she was brought by her 
sister. She claimed to be feeling better. No more 
palpitations, no more heat intolerance, no more 
sweatiness. So this second patient was examined 
and found to have a goitre, exophthalmos, but had 
no toxic features of warm sweaty palms, no 
tachycardia, blood pressure was 130/80mmHg 
supine. A diagnosis of euthyroid Graves' disease 
was made.  Patient who had been off drugs for one 
month was not restarted on drugs. She was 
monitored by clinic follow-up visits and estimation 
of thyroid hormone concentration. Her hormones 
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had been within the laboratory's reference range 
and became  elevated after 18 months. Patient was 
thereafter restarted on carbimazole and 
propranolol. The two patients have continue to 
come for follow-up in our hospital. The disease has 
been well controlled on antithyroids and they are on 
maintenance dosages. The exophthalmos has 
markedly regressed with prednisolone and the 
goitre has reduced in both patients.
Second Family:
O. O. was the index case of this family. She was a  
26 year old married undergraduate student. She had 
had bilateral protrusion of the eye balls two years 
before presentation. She had gone to a peripheral 
hospital where she was placed on carbimazole and 
propranolol. A year after the protrusion of the eye 
balls, she became pregnant and she stopped the 
drugs on her own because she thought she was well. 
Four months after delivery, she presented to our 
hospital with worsening palpitations, heat 
intolerance, weight loss despite good appetite, 
worsening of the bulging of the eye balls and 
increase in size of the goitre. Patient's immediate 
younger sister and a paternal aunt also was said to 
be suffering from similar symptoms of bulging of 
the eye balls and goitre for which they were 
receiving treatment elsewhere.
 
Examination revealed a young woman that was not 
2in distress. Her body mass index was 28kg/m . She 
had exophthalmos, diffuse goitre which was non-
tender, warm moist sweaty palms, onycholysis, and 
palmar erythema. She had a tachycardia of 
130/min, that was regular with a blood pressure of 
120/60mmHg supine. Investigations done - Full 
blood count, serum proteins, calcium and 
phosphorus - were all within the laboratory's 
reference range, except for thyroid hormones that 
were  e l eva ted .  (Thyrox ine=293nml /L ,  
triiodothyronine=8.1nmol/L, thyrotropin= 
0.1m.i.u/L). A diagnosis of familial Graves' disease 
was made and patient was restarted on carbimazole 
and propranolol. She did well on the treatment and 
has continued with follow-up.
Third Family:
The index patient was NN. NN was a 22 year old 
female undergraduate student who presented to the 
ophthalmology clinic for progressive bilateral 
bulging of the eye balls. She had not been aware of 
any other symptom including goitre. She was 
referred to our medical unit because of the 
associated finding of elevated thyroid hormones by 
the ophthalmologist. Patient's younger brother and 
mother had earlier on visited a Doctor in a 
peripheral hospital for recent onset protrusion of the 
eye balls for which they had been placed on some 
tablet. Patient was found to have a  diffuse goitre 
and exophthalmos with some features of 
thyrotoxicosis such as warm moist palms, 
onycholysis, palmar erythema and profuse 
sweating. Her thyroid hormone levels were 
markedly elevated with low serum thyrotropin.
DISCUSSION:
Among the three families, eight (8) persons had 
Graves' disease: seven women and one man. This 
finding brings out the ratio of 7:1. This ratio is 
1, 4, 5
similar to what other thyroid researchers  have 
documented. The presentation of these patients; 
diffuse goitre with bilateral exophthalmos led to the 
diagnosis of familial Graves' disease - the Graves' 
disease that is seen commonly in the population. 
This shows that these are the two common 
diagnostic features of Graves' disease. Pretibial 
myxoedema was not seen at all in any of these 
patients meaning that it is a rare finding even in 
thyrotoxicosis of Graves, disease. 
These patients responded well to the ordinary 
antithyroid agents that are used for other patients. 
These are a combination of carbimazole in various 
dosages with propranolol also in various dosages 
depending on the heart rate - more in tachycardia. 
Patients never agreed for surgery even when thyroid 
gland was big. This response is different from that 
seen in other cases of familial hyperthyroidism 
because, these have a different aetiological agent. 
Rosler et al reported familial hyperthyroidism due 
to inappropriate thyrotropin secretion affecting six 
(6) females in a family of three generations. The 
pa t ien t s  were  success fu l  t r ea ted  wi th  
triiodothyronine. Autosomal dominant non-
autoimmune hereditary familial hyperthyroidism, 
accounting for a very small proportion of the causes 
of hereditary familial thyrotoxicosis, may not be 
successfully treated with antithyroid agents unless 
the aetiological factor is addressed. It is however, to 
be noted that Graves' disease may result from an 
interplay of more than one gene defects, 
contribution to it being probably a multifactorial 
disease.      
Graves' disease has not been the leading cause of 
thyrotoxicosis in iodine-deficient areas of the world 
1 0 , 11 , 1 2but toxic multinodular goitre . With 
improvement in iodization of foodstuff like salt and 
drinking water, the prevalence of multinodular 
goitre that will eventually become toxic, will 
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reduce. Graves' disease, therefore will take pre-
eminence as the leading cause of thyrotoxicosis 
because infection, still present in these areas of the 
world will trigger off a chain of antibody 
production leading to thyroid activation resulting 
in Graves' disease. However, familial Graves' 
disease is the commonest in a group of disorders 
called hereditary familial thyrotoxicosis .It has 
9
been reported among 4 families from Ibadan , but 
the patients in their report did not all have Graves' 
disease because some of the patients had diffuse 
goitre that may be present in other conditions and 
no exophthalmos, and pretibial myxoedema. The 
patients in this case report together with their 
relations all had Graves' disease as all had 
exophthalmos with goitre. However, exophthalmos 
distinguishes these patients with Graves' disease 
from those reported by Thomas et al. Thomas 
described a non-autoimmune form of the goitrous 
hyperthyroidism.  Graves' disease can begin 
without exophthalmos but the exophthalmos may 
appear after the treatment has been initiated. 
Despite the presence of exophthalmos in these 
patients analysis is in no doubt necessary for 
susceptibility determinant or association. These 
genetic studies will help classify the type of genetic 
disorder whether it is HLA alleleic mutations, 
polymorphism in cytotoxic T-lymphocyte antigen 
4 or the polymorphism in the vitamin D - binding 
protein gene. With this determination, solutions 
may be proffered to each individual patient 
accordingly.
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